drugset / Trial / NCT01129453
Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection
Phase 1
Completed
51 enrolled
University of Maryland, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine whether CVD 1902 (a live, attenuated, oral vaccine) is safe and effective in the prevention of Salmonella enterica serovar paratyphi A infection.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-12
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CVD 1902 | Vaccine | 1e+06 unknown | Oral |
| Subject | CVD 1902 | Vaccine | 1e+07 unknown | Oral |
| Subject | CVD 1902 | Vaccine | 1e+08 unknown | Oral |
| Subject | CVD 1902 | Vaccine | 1e+09 unknown | Oral |